Cargando…

Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation

Studies have shown that papaverine can inhibit lipopolysaccharide (LPS)-induced microglial activation. The retinal primary microglia of newborn SD rats were isolated and purified, and a LPS-induced microglia activation model was established. The protein phosphorylation level of the signaling pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ting, Zhu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453874/
https://www.ncbi.nlm.nih.gov/pubmed/30852743
http://dx.doi.org/10.1007/s12031-019-01289-w
_version_ 1783409454026326016
author Zhou, Ting
Zhu, Yu
author_facet Zhou, Ting
Zhu, Yu
author_sort Zhou, Ting
collection PubMed
description Studies have shown that papaverine can inhibit lipopolysaccharide (LPS)-induced microglial activation. The retinal primary microglia of newborn SD rats were isolated and purified, and a LPS-induced microglia activation model was established. The protein phosphorylation level of the signaling pathway was detected by western blotting. The transcription and expression of TNF-α, IL-1β, and IL-10 were respectively detected by RT-PCR and ELISA to observe the abnormal activation of primary microglia. The cAMP inhibitor Rp-isomer, PKA inhibitor H89, and MEK inhibitor U0126 were separately added to further investigate the role of MEK/Erk in PAP inhibition of primary microglial activation and the relationship between cAMP/PKA and MEK/Erk. It was found that the level of MEK phosphorylation was upregulated after LPS stimulation, which was blocked by 10 μg/ml of papaverine.10μM U0126 significantly inhibited TNF-α and IL-1β and increased IL-10 transcription and expression in retinal microglia (P < 0.01). Both Rp-isomer and H89 upregulated the phosphorylation levels of MEK and Erk. Papaverine may inhibit inflammatory factors and promote the expression of anti-inflammatory factors through the cAMP/PKA and MEK/Erk pathway, thereby inhibiting LPS-induced activation of primary retinal microglia, and the MEK/Erk pathway may be partially regulated by cAMP/PKA, which can provide theoretical basis and experimental basis for its protection of the central nervous system.
format Online
Article
Text
id pubmed-6453874
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-64538742019-04-26 Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation Zhou, Ting Zhu, Yu J Mol Neurosci Article Studies have shown that papaverine can inhibit lipopolysaccharide (LPS)-induced microglial activation. The retinal primary microglia of newborn SD rats were isolated and purified, and a LPS-induced microglia activation model was established. The protein phosphorylation level of the signaling pathway was detected by western blotting. The transcription and expression of TNF-α, IL-1β, and IL-10 were respectively detected by RT-PCR and ELISA to observe the abnormal activation of primary microglia. The cAMP inhibitor Rp-isomer, PKA inhibitor H89, and MEK inhibitor U0126 were separately added to further investigate the role of MEK/Erk in PAP inhibition of primary microglial activation and the relationship between cAMP/PKA and MEK/Erk. It was found that the level of MEK phosphorylation was upregulated after LPS stimulation, which was blocked by 10 μg/ml of papaverine.10μM U0126 significantly inhibited TNF-α and IL-1β and increased IL-10 transcription and expression in retinal microglia (P < 0.01). Both Rp-isomer and H89 upregulated the phosphorylation levels of MEK and Erk. Papaverine may inhibit inflammatory factors and promote the expression of anti-inflammatory factors through the cAMP/PKA and MEK/Erk pathway, thereby inhibiting LPS-induced activation of primary retinal microglia, and the MEK/Erk pathway may be partially regulated by cAMP/PKA, which can provide theoretical basis and experimental basis for its protection of the central nervous system. Springer US 2019-03-09 2019 /pmc/articles/PMC6453874/ /pubmed/30852743 http://dx.doi.org/10.1007/s12031-019-01289-w Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Zhou, Ting
Zhu, Yu
Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation
title Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation
title_full Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation
title_fullStr Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation
title_full_unstemmed Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation
title_short Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation
title_sort cascade signals of papaverine inhibiting lps-induced retinal microglial activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453874/
https://www.ncbi.nlm.nih.gov/pubmed/30852743
http://dx.doi.org/10.1007/s12031-019-01289-w
work_keys_str_mv AT zhouting cascadesignalsofpapaverineinhibitinglpsinducedretinalmicroglialactivation
AT zhuyu cascadesignalsofpapaverineinhibitinglpsinducedretinalmicroglialactivation